نتایج جستجو برای: nhl cell line model

تعداد نتایج: 3815069  

Journal: :Blood 2009
Ajay K Gopal John M Pagel Jonathan R Fromm Shani Wilbur Oliver W Press

Radioimmunotherapy (RIT) options for T-cell non-Hodgkin lymphomas (T-NHLs) are limited. We evaluated anti-CD45-RIT in human (h) and murine (m) T-NHL. CD45 was highly expressed on hT-NHL patient samples (median, 2.3 x 10(5) antigen-binding capacity units/cell) and hT-NHL cell lines (3.4 x 10(5) CD45 antigen-binding capacity units/cell). Biodistribution studies in hTNHL xenografts showed that (13...

Journal: :Blood 1994
J Suzumiya M Takeshita N Kimura M Kikuchi T Uchida S Hisano Y Eura M Kozuru Y Nomura K Tomita

The majority of sinonasal non-Hodgkin's lymphomas (NHLs) are thought to originate from T-cell lineage. However, they often express natural killer (NK)-cell markers so that their origin still remains obscure. In this study, cell type of sinonasal NHLs were characterized by immunohistochemical and Southern blot analyses. We examined nine patients with sinonasal NHL. Six patients with tonsillar or...

2018
Giuseppe Gritti Andrea Gianatti Fiorella Petronzelli Rita De Santis Chiara Pavoni Riccardo Lorenzo Rossi Laura Cattaneo Luigi Giusto Spagnoli Silvia Ferrari Andrea Rossi Anna Maria Barbui Alessandro Rambaldi

The clinical outcome of T-cell non-Hodgkin lymphoma (NHL) is poor and innovative treatments are needed. Tenascin-C is a large extracellular glycoprotein not expressed under physiological conditions, but overexpressed in cancer. Aim of the study was to evaluate tenascin-C expression within pathologic tissue of T-cell NHL and determine its clinical significance. We used an immunohistochemistry ap...

2014
Shi-Jun Li Hui-Ping Chen Ying-Hua Chen Li-hua Zhang Yuan-Mao Tu Zhi-hong Liu

AIMS To determine the spectrum of renal lesions in patients with kidney involvement in non-Hodgkin's lymphoma (NHL) by renal biopsy. METHODS The clinical features and histological findings at the time of the renal biopsy were assessed for each patient. RESULTS We identified 20 patients with NHL and renal involvement, and the diagnosis of NHL was established following the kidney biopsy in 18...

2017
Saheli Sarkar Pooja Sabhachandani Dashnamoorthy Ravi Sayalee Potdar Sneha Purvey Afshin Beheshti Andrew M. Evens Tania Konry

Natural killer (NK) cells are phenotypically and functionally diverse lymphocytes that recognize and kill cancer cells. The susceptibility of target cancer cells to NK cell-mediated cytotoxicity depends on the strength and balance of regulatory (activating/inhibitory) ligands expressed on target cell surface. We performed gene expression arrays to determine patterns of NK cell ligands associate...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammadali mashhadi hematology- oncology department, zahedan university of medical sciences, zahedan, iran hossein rahimi hematology- oncology department, mashhad university of medical sciences, mashhad, iran behrooz najafi hematology- oncology department, gilan university of medical sciences, gilan, iran adnan khosravi hematology- oncology department, shahid beheshti university of medical sciences, tehran, iran

introduction: management of early relapsed or refractory lymphoma [hodgkin & non- hodgkin lymphoma (hl & nhl)] is a matter of problem, especially when hematopietic stem cell support is not available. the aim of this study was to evaluate effectiveness of iev regimen ( ifosfamide, epirubicin, vp16), in lymphoma patients who are not candidate for stem cell transplantation. because the majority of...

2014
Kan Zhai Jie Ding Yan Zhou

Tumor necrosis factor-α (TNF-α) is an immunoregulatory cytokine involved in B- and T-cell function, and also plays an important role in inflammation and cancer. TNF-α-308G>A has been associated with constitutively elevated TNF-α expression. Several studies have reported the association between the TNF-α-308G>A polymorphism and non-Hodgkin lymphomas (NHL) risk, however, results are still inconsi...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2014
L Arcaini D Vallisa S Rattotti V V Ferretti A J M Ferreri P Bernuzzi M Merli M Varettoni A Chiappella A Ambrosetti A Tucci C Rusconi C Visco M Spina G Cabras S Luminari M Tucci P Musto M Ladetto F Merli C Stelitano A d'Arco L Rigacci A Levis D Rossi P Spedini S Mancuso D Marino R Bruno L Baldini A Pulsoni

BACKGROUND Tumor regression after antiviral therapy (AT) is in favor of an etiological role of hepatitis C virus (HCV) in non-Hodgkin's B-cell lymphomas (NHL). PATIENTS AND METHODS We carried out a cohort study of 704 consecutive HIV-negative, HCV-positive patients with indolent NHL diagnosed and treated from 1993 to 2009 in 39 centers of the Fondazione Italiana Linfomi; 134 patients were man...

Journal: :iranian journal of pharmaceutical research 0
bardia jamali biopharmaceutics and pharmacokinetics division, department of pharmaceutics, faculty of pharmacy, tehran university of medical sciences, tehran, iran. maryam nakhjavani department of toxicology & pharmacology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, iran. leila hosseinzadeh toxicology and pharmacology department, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran. salimeh amidi department of medicinal chemistry, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. nastaran nikonezhad department of toxicology, sbmu pharmacy school, tehran, iran. farshad h. shirazi sbmu pharmaceutical sciences research center, p.o.box 14155-3817, tehran, iran.

one of the major complications in cancer chemotherapy is the development of resistance, and cisplatin, as one of the important medicines in treatment regimens of different cancers is not excluded. one of the most described cellular defense mechanisms involved in resistance is glutathione (gsh) and in this study, the effects of cisplatin on the total intracellular gsh level (gshi) in some sensit...

2013
Stephen E. Spurgeon Greg Coffey Luke B. Fletcher Russell Burke Jeffrey W. Tyner Brian J. Druker Andreas Betz Francis DeGuzman Yvonne Pak Dale Baker Anjali Pandey Stanley J. Hollenbach Uma Sinha Marc M. Loriaux

B-cell receptor (BCR) associated kinases including spleen tyrosine kinase (SYK) contribute to the pathogenesis of B-cell malignancies. SYK is persistently phosphorylated in a subset of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL), and SYK inhibition results in abrogation of downstream kinase activity and apoptosis. P505-15 (also known as PRT062607) is a novel, highly select...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید